Osmotic device for protracted pulsatile delivery of agent

• US 5,498,255 A
• Filed: 05/15/1995
• Issued: 03/12/1996
• Est. Priority Date: 08/17/1993
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Wong, Patrick S.-L.
• Primary Examiner(s): Rosenbaum, C. Fred
• Assistant Examiner(s): Alexander, V.
• Application Number:
  US08/442,716
• Time in Patent Office: 302 Days
• Field of Search: 604/892.1, 604/890.1, 604/891.1, 424/453, 424/468, 424/471, 424/472, 424/474, 424/462, 424/463, 424/48, 424/473, 424/422-424
• US Class Current: 604/892.1
• CPC Class Codes: A61K 9/0004 Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Abstract

The present invention is directed to a fluid-imbibing dispensing device for the extended or protracted delivery of an active agent following an initially delayed startup of the delivery to a fluid environment of use. The dispenser comprises a housing having a first wall section and a second wall section in reversibly sliding telescopic arrangement with each other, which housing maintains its integrity in the environment of use; an internal compartment surrounded and defined by the housing; at least one active agent formulation in a portion of the compartment defined by the first wall section; at least one opening in the side wall of the first wall section, each opening extending longitudinally along a portion of the side wall of the first wall section for providing communication between the active agent formulation and the environment; expansion means within a portion of the compartment defined by the second wall section, for separating apart the first and second wall sections of the housing after exposure to the environment of use; and, optionally, a partition layer or push plate between the active agent formulation and the expansion means.

Claims

1. A fluid-imbibing delivery device for dispensing an active agent to a fluid environment of use for an extended period of time following an initial delayed startup of delivery, wherein the device comprises:

a) a housing comprising a first wall section and a second wall section in reversibly sliding telescopic arrangement with each other, the first wall section having an open end adapted to fit within the second wall section and the second wall section comprising in at least a portion a semipermeable composition, which housing maintains its integrity in the environment of use;

b) an internal compartment surrounded and defined by the first and second wall sections of the housing;

c) at least one active agent formulation comprising a drug in a portion of the compartment defined by the first wall section;

d) at least one opening in the side wall of the first wall section, each opening extending longitudinally along a portion of the side wall of the first wall section and beinq covered by said second wall section prior to exposure to the environment of use, for releasing the active agent formulation comprising the drug followinfi separation of the first and second wall sections upon exposure to the environment of use; and

e) expansion means comprising an osmopolymer in a portion of the compartment defined by the second wall section, for separating apart the first and second wall sections of the housing after exposure to the environment of use.

2. A delivery device according to claim 1 wherein there are two to ten openings in the side wall of the first wall section.

3. A delivery device according to claim 1 wherein the first wall section is comprised of a substantially impermeable composition.

4. A dispensing device according to claim 1 wherein the active agent formulation comprises a liquid, a solid, a semisolid, a thermoresponsive composition, or a plurality of dosage forms.

5. A dispensing device according to claim 1 which further comprises a push plate between the expansion means and the open end of the first wall section.

6. A method for delivering an active agent comprising a drug to a fluid environment of use for an extended period of time following an initial delayed startup of delivery, wherein the device comprises:

1) placing a delivery device into the environment of use, the dispensing device comprising;

a) a housing comprising a first wall section and a second wall section in reversibly sliding telescopic arrangement with each other, the first wall section having an open end adapted to fit within the second wall section and the second wall section comprising in at least a portion a semipermeable composition, which housing maintains its integrity in the environment of use;

b) an internal compartment surrounded and defined by the first and second wall sections of the housing;

c) at least one active agent formulation comprising a drug in a portion of the compartment defined by the first wall section;

d) at least one opening in the side wall of the first wall section, each opening extending longitudinally along a portion of the side wall of the first wall section and beinq covered by said second wall section prior to exposure to the environment of use, for releasing the active agent formulation comprising the drug followinq separation of the first and second wall sections upon exposure to the environment of use; and

e) expansion means comprising an osmopolymer in a portion of the compartment defined by the second wall section, for separating apart the first and second wall sections of the housing after exposure to the environment of use;

2) allowing fluid to be imbibed through at least a portion of the second wall section of the housing of the dispensing device for causing the expansion means to expand and exert pressure on the slidably connected first and second wall sections to push apart and separate the first and second wall sections to deliver the active agent formulation comprising the drug through the at least one opening in the side wall of the first wall section to the environment over an extended period of time after an initially delayed period of time.

7. A method according to claim 6 wherein there are two to ten openings in the side wall of the first wall section.

8. A method according to claim 6 wherein the first wall section is comprised of a substantially impermeable composition.

9. A method according to claim 6 wherein the active agent formulation comprises a liquid, a solid, a semisolid, a thermoresponsive composition, or a plurality of dosage forms.

10. A method according to claim 6 which further comprises a push plate between the expansion means and the open end of the first wall section.